NasdaqGM - Nasdaq Real Time Price USD
Apogee Therapeutics, Inc. (APGE)
70.02 -9.84 (-12.32%)
At close: 4:00:02 PM EST
69.43 -0.59 (-0.84%)
After hours: 4:48:34 PM EST
Chart Range Bar
Loading chart for APGE
- Previous Close
79.86 - Open
78.17 - Bid 69.67 x 200
- Ask 70.33 x 200
- Day's Range
67.97 - 78.78 - 52 Week Range
26.20 - 84.56 - Volume
4,152,693 - Avg. Volume
855,754 - Market Cap (intraday)
4.784B - Beta (5Y Monthly) 1.42
- PE Ratio (TTM)
-- - EPS (TTM)
-4.38 - Earnings Date Nov 10, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
104.43
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
www.apogeetherapeutics.comRecent News: APGE
View More
Performance Overview: APGE
Trailing total returns as of 1/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
APGE
7.23%
S&P 500 (^GSPC)
1.02%
1-Year Return
APGE
74.14%
S&P 500 (^GSPC)
13.02%
3-Year Return
APGE
225.67%
S&P 500 (^GSPC)
72.04%
5-Year Return
APGE
225.67%
S&P 500 (^GSPC)
80.03%
Earnings Trends: APGE
View MoreAnalyst Insights: APGE
View MoreStatistics: APGE
View MoreValuation Measures
As of 1/22/2026
Market Cap
5.46B
Enterprise Value
4.94B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
9.31
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-25.26%
Return on Equity (ttm)
-38.41%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-253.67M
Diluted EPS (ttm)
-4.38
Balance Sheet and Cash Flow
Total Cash (mrq)
527.29M
Total Debt/Equity (mrq)
1.68%
Levered Free Cash Flow (ttm)
-143.33M
Compare To: APGE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: APGE
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.